High levels of cerebrospinal fluid soluble triggering receptor expressed on myeloid cells 2 might be a biomarker of activity in pediatric patients with MOG-AD

• Κύριοι συγγραφείς: Anna Zhou (Συγγραφέας), Weihua Zhang (Συγγραφέας), Changhong Ren (Συγγραφέας), Ji Zhou (Συγγραφέας), Haoxiao Chang (Συγγραφέας), Xiaotun Ren (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Myelin oligodendrocyte glycoprotein antibody disease (MOG-AD) is characterized by its monophasic or relapsing course and inflammatory demyelinating condition which is unable to be classified in typical multiple sclerosis (MS) or other known neuroinflammatory conditions. In the condition of neuroinfl...